RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Eve Dryer

An esteemed leader in rare disease patient advocacy and healthcare communications with over 25 years of experience, recently retired from her role as VP of Patient Advocacy at Travere Therapeutics. Throughout her career, she has been a driving force in advancing health literacy and improving outcomes in underserved communities. Formerly, she founded and led Vox Medica’s PR and patient advocacy practices, earning accolades such as five Silver Anvil Awards and recognition in the PharmaVOICE 100. Eve’s dedication extends to her roles on the Board of Sisters Network Inc. and as a past chair of HealthyWomen’s Board of Directors. Her legacy includes championing patient diversity and inclusion initiatives, including her role in founding the Rare Disease Diversity Coalition and Travere’s internal Rare Disease Patient Advisory Council. With impactful endeavors like Teens for Pink (focused on African American breast cancer) and her leadership at a Philadelphia-based healthcare PR agency, Eve continues to be a pivotal figure in healthcare advocacy.

Philadelphia, PA

Related News

NEWS

NephCure Announces First-Ever IgA Nephropathy (IgAN) Awareness Day on September 26, 2024 

JULY 27, 2023

NEWS

Reykjavik Meeting Propels PARASOL Project Forward in FSGS Treatment Revolution 

JULY 27, 2023

NEWS

FDA Grants Fabhalta Accelerated Approval for Treatment of IgA Nephropathy in Adults

JULY 27, 2023

NEWS

Kidney Health Advocates from Across the Country Urge Congress to Support the New Era Act During NephCure’s Rare Kidney Day at the U.S. Capitol

JULY 27, 2023

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.